Уважаемые пользователи!
Мы рады представить вам новую версию сайта с улучшенным интерфейсом и новыми возможностями.
Приглашаем вас ознакомиться и поделиться обратной связью. Спасибо, что вы с нами!
Попробовать!

Worsening Renal Function and Outcome in Heart Failure Patients With Preserved Ejection Fraction and the Impact of Angiotensin Receptor Blocker Treatment

12.09.20141770
What is the relationship between worsening renal failure (WRF) and outcomes in heart failure patients with preserved ejection fraction (HFpEF), and the interaction with renin-angiotensin-aldosterone system (RAAS) blockade?

Statin use before diabetes diagnosis and risk of microvascular disease: a nationwide nested matched study

11.09.20142060
The role of statins in the development of microvascular disease in patients with diabetes is unknown.

Analysis of resting heart rate and clinical characteristics in outpatients with stable coronary artery disease in Turkey: PULSE study

10.09.20141567
An association between resting heart rate (RHR) and cardiovascular morbidity and mortality has been shown in patients with coronary artery disease (CAD).

FDA grants clearance for mobile AF detection algorithm

09.09.20141690
AliveCor Inc. announced that it has received clearance from the FDA for an algorithm designed to detect atrial fibrillation using a mobile device.

New ESC Guidelines on pulmonary embolism

08.09.20142539
ESC Guidelines on the management of patients with pulmonary embolism (PE) have been released during this congress and provide clinicians with a user-friendly summary of current evidence in the field.

Potent Statin Offers No Help After Cardiac Surgery

05.09.20141719
The powerful lipid-lowering drug rosuvastatin (Crestor) -- also purported to be an effective anti-inflammatory agent -- was powerless to prevent postoperative cardiac surgery complications such as atrial fibrillation in a randomized trial reported here.

Complete versus Lesion-only PRimary PCI Trial

04.09.20141748
Management of multivessel coronary disease during primary percutaneous coronary intervention (PCI) remains controversial. Current guidelines recommend treating the infarct-related artery.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.